In an interview with Technology Networks, Dr. Daniel Reker discusses how machine learning is improving data-scarce areas of drug discovery.
Bioinformaticians have been utilizing machine learning for years. However, the introduction of powerful and easily accessible generative AI tools is a new horizon. Learning how to use these tools to ...
Antimicrobial resistance (AMR) is diminishing the effectiveness of existing antibiotics and intensifying the need for discovery pipelines that are both ...
A signal-processing–based framework converts DNA sequences into numerical signals to identify protein-coding regions. By integrating spectral analysis and SVM classification, the approach improves ...
In some ways, Java was the key language for machine learning and AI before Python stole its crown. Important pieces of the data science ecosystem, like Apache Spark, started out in the Java universe.
The data science and machine learning technology space is undergoing rapid changes, fueled primarily by the wave of generative AI and—just in the last year—agentic AI systems and the large language ...
Forbes contributors publish independent expert analyses and insights. Writes about the future of finance and technology, follow for more. We live in a world where machines can understand speech, ...
Until now, designing complex metamaterials with specific mechanical properties required large and costly experimental and simulation datasets. The method enables ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results